Citadel L5This page contains information on Citadel L5 for veterinary use.
The information provided typically includes the following:
- Citadel L5 Indications
- Warnings and cautions for Citadel L5
- Direction and dosage information for Citadel L5
Citadel L5This treatment applies to the following species:
Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
Citadel L5 Indications
In cattle, for the prevention of urinary shedding of L. borgpetersenii serovar hardjo (type hardjo-bovis). Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure. For vaccination of healthy, susceptible cattle and swine as an aid in the reduction of leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
Dosage: Using aseptic technique, inject 2 mL subcutaneously or intramuscularly in healthy cattle of any age, or intramuscularly in swine of any age. A second dose is recommended 3 to 6 weeks later. Cattle and swine vaccinated at an early age should be revaccinated after weaning. Repeat with a single 2 mL booster dose annually or prior to each breeding.
PrecautionsStore out of direct sunlight at 35 - 45°F (2 - 7°C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur. Antidote: Epinephrine.
Preservatives: Neomycin and thimerosal.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
U.S. Veterinary License No. 124
50 Doses/100 mL
NAC No.: 10282850
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Citadel L5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10